Mr. Traynor previously spent 10 years at Genzyme Corporation, most recently serving as senior vice president of business unit finance. At ConforMIS he will be responsible for SEC filings, controllership functions and financial planning and forecasting for Genzyme’s eight global business units.
More Articles on Orthopedic Device Companies:
15 Device Company Financial Reports
Tornier 3Q Sales Flat at $58M
DePuy Launches New Trumatch Pin for Orthopedic Implants
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.